Bank of America’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $395K | Buy |
109,739
+49,078
| +81% | +$177K | ﹤0.01% | 4932 |
|
|
2025
Q1 | $181K | Sell |
60,661
-12,780
| -17% | -$38.2K | ﹤0.01% | 5264 |
|
|
2024
Q4 | $246K | Buy |
73,441
+13,902
| +23% | +$46.6K | ﹤0.01% | 5154 |
|
|
2024
Q3 | $199K | Sell |
59,539
-9,938
| -14% | -$33.3K | ﹤0.01% | 5146 |
|
|
2024
Q2 | $230K | Buy |
69,477
+2,411
| +4% | +$7.98K | ﹤0.01% | 5015 |
|
|
2024
Q1 | $271K | Sell |
67,066
-176,658
| -72% | -$714K | ﹤0.01% | 4896 |
|
|
2023
Q4 | $743K | Buy |
243,724
+147,292
| +153% | +$449K | ﹤0.01% | 4353 |
|
|
2023
Q3 | $289K | Sell |
96,432
-6,078
| -6% | -$18.2K | ﹤0.01% | 4832 |
|
|
2023
Q2 | $383K | Sell |
102,510
-34,013
| -25% | -$127K | ﹤0.01% | 4639 |
|
|
2023
Q1 | $457K | Sell |
136,523
-37,823
| -22% | -$127K | ﹤0.01% | 4669 |
|
|
2022
Q4 | $839K | Buy |
174,346
+45,867
| +36% | +$221K | ﹤0.01% | 4323 |
|
|
2022
Q3 | $731K | Buy |
128,479
+83,226
| +184% | +$474K | ﹤0.01% | 4398 |
|
|
2022
Q2 | $321K | Buy |
45,253
+7,740
| +21% | +$54.9K | ﹤0.01% | 5024 |
|
|
2022
Q1 | $271K | Sell |
37,513
-86,865
| -70% | -$628K | ﹤0.01% | 5526 |
|
|
2021
Q4 | $1.11M | Buy |
124,378
+88,748
| +249% | +$793K | ﹤0.01% | 4430 |
|
|
2021
Q3 | $1.25M | Sell |
35,630
-29,269
| -45% | -$1.03M | ﹤0.01% | 4164 |
|
|
2021
Q2 | $1.39M | Buy |
64,899
+40,589
| +167% | +$872K | ﹤0.01% | 3998 |
|
|
2021
Q1 | $1.5M | Buy |
24,310
+10,118
| +71% | +$625K | ﹤0.01% | 3952 |
|
|
2020
Q4 | $593K | Buy |
+14,192
| New | +$593K | ﹤0.01% | 4212 |
|